Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin
Author:
Publisher
Elsevier BV
Subject
Oncology,General Medicine,Surgery
Reference29 articles.
1. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy;Sugarbaker;Ann Surg,1995
2. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin;Elias;J Clin Oncol,2008
3. An overview of peritonectomy, visceral resection, and therapeutic laparoscopy for peritoneal surface malignancy;Sugarbaker,2017
4. Cancer chemotherapy for peritoneal metastases: pharmacology and treatment;Van der Speeten,2017
5. Consensus guidelines from the American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States;Turaga;Ann Surg Oncol,2014
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Unraveling the immune landscape and therapeutic biomarker PMEPA1 for oxaliplatin resistance in colorectal cancer: A comprehensive approach;Biochemical Pharmacology;2024-04
2. Efficacy of hyperthermic intraperitoneal chemotherapy in colorectal cancer: A phase I and III open label randomized controlled registry-based clinical trial protocol;PLOS ONE;2024-03-04
3. FDFT1 Reduces Stemness and Autocrine/Juxtacrine Signaling in FOLFOX-resistant Colon Cancer Cells;J BIOL REG HOMEOS AG;2024
4. Novel insights into the role of translesion synthesis polymerase in DNA incorporation and bypass of 5-fluorouracil in colorectal cancer;Nucleic Acids Research;2024-02-28
5. Activating CD8+ T Cells by Pt(IV) Prodrug‐Based Nanomedicine and aPD‐L1 Antibody for Enhanced Cancer Immunotherapy;Advanced Materials;2024-02-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3